IL33 and myocardial infarction: Additionally, IL-33 has been shown to prevent cardiomyocyte apoptosis, improve cardiac function and survival post-myocardial infarction via ST2 signaling (13), and reduce mortality in experimental sepsis by enhancing neutrophil influx to infection sites (37).